Skip to main content
Log in

The influence of magnetic resonance tomography on diagnosis and therapy in patients with intracranial manifestation of neurofibromatosis (Recklinghausen disease)

  • Original articles
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Recent research into the natural course of neurofibromatosis has revealed an outstandingly high proportion of central nervous system malignancies as well as cancers of various other organs. Due to the lack of ionizing radiation, the extraordinary reconstruction in the frontal and parasaggital planes as well as the diagnosis of intracanalicular acoustic neurinomas and intraorbital tumors, magnetic resonance tomography (MRT) is indicated for control of patients with neurofibromatosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Rodriguez HA, M Berthrong: Multiple primary intracranial tumors in von Recklinghausen's neurofibromatosis. Arch Neurol 14 (1966) 467–475

    PubMed  Google Scholar 

  2. Rubinstein LJ: Tumors of the Central Nervous System. Atlas of tumor pathology, second series, fascicle 6, 302–309. Armed Forces Institute of Pathology, Washington D. C. 1981

    Google Scholar 

  3. Rubinstein LJ: Tumeurs et Hamartomes dans la Neurofibromatose Centrale. In:Michaux L, M Feld (eds.): Les Phakomatoses Cérébrales. Editeurs, Paris 1963 S.P.E.I.

    Google Scholar 

  4. Soerensen SA, JJ Mulvihill, A Nielsen: Long-Term Follow-Up of von Recklinghausen Neurofibromatosis. N Eng-J Med 314 (1986) 1010–1015

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiwit, J.C.W., Nicola, N., Roosen, N. et al. The influence of magnetic resonance tomography on diagnosis and therapy in patients with intracranial manifestation of neurofibromatosis (Recklinghausen disease). Neurosurg. Rev. 10, 283–286 (1987). https://doi.org/10.1007/BF01781951

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01781951

Keywords

Navigation